1. Home
  2. XYLO vs ICCT Comparison

XYLO vs ICCT Comparison

Compare XYLO & ICCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYLO
  • ICCT
  • Stock Information
  • Founded
  • XYLO 1999
  • ICCT 1992
  • Country
  • XYLO Israel
  • ICCT United States
  • Employees
  • XYLO N/A
  • ICCT N/A
  • Industry
  • XYLO
  • ICCT Computer Software: Prepackaged Software
  • Sector
  • XYLO
  • ICCT Technology
  • Exchange
  • XYLO NYSE
  • ICCT Nasdaq
  • Market Cap
  • XYLO 3.1M
  • ICCT 2.9M
  • IPO Year
  • XYLO N/A
  • ICCT N/A
  • Fundamental
  • Price
  • XYLO $5.00
  • ICCT $0.67
  • Analyst Decision
  • XYLO
  • ICCT
  • Analyst Count
  • XYLO 0
  • ICCT 0
  • Target Price
  • XYLO N/A
  • ICCT N/A
  • AVG Volume (30 Days)
  • XYLO 11.5K
  • ICCT 1.7M
  • Earning Date
  • XYLO 04-21-2025
  • ICCT 04-21-2025
  • Dividend Yield
  • XYLO N/A
  • ICCT N/A
  • EPS Growth
  • XYLO N/A
  • ICCT N/A
  • EPS
  • XYLO N/A
  • ICCT N/A
  • Revenue
  • XYLO $57,642,000.00
  • ICCT $11,049,477.00
  • Revenue This Year
  • XYLO $16.76
  • ICCT N/A
  • Revenue Next Year
  • XYLO $5.71
  • ICCT N/A
  • P/E Ratio
  • XYLO N/A
  • ICCT N/A
  • Revenue Growth
  • XYLO N/A
  • ICCT 42.66
  • 52 Week Low
  • XYLO $2.70
  • ICCT $0.61
  • 52 Week High
  • XYLO $8.83
  • ICCT $35.80
  • Technical
  • Relative Strength Index (RSI)
  • XYLO 61.43
  • ICCT 24.50
  • Support Level
  • XYLO $3.77
  • ICCT $0.61
  • Resistance Level
  • XYLO $5.00
  • ICCT $1.35
  • Average True Range (ATR)
  • XYLO 0.46
  • ICCT 0.22
  • MACD
  • XYLO 0.06
  • ICCT -0.07
  • Stochastic Oscillator
  • XYLO 80.81
  • ICCT 3.74

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.

About ICCT iCoreConnect Inc. Common stock

iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.

Share on Social Networks: